David Rosmarin, MD: How to Use Ruxolitinib Cream for Vitiligo
Dr. Rosmarin highlights his presentation from AAD 2025, in which he reviewed the optimal method for using ruxolitinib cream for vitiligo, touching on setting patient expectations, pigmentation timelines, and response rates among patient sub-groups, and navigating any potential side effects.
Iltefat Hamzavi, MD: Carbon Dioxide Laser for Hidradenitis Suppurativa
Dr. Hamzavi discusses key points from his presentation within the AAD 2025 session on surgical options for hidradenitis suppurativa.
Raj Chovatiya, MD, PhD: Chronic Hand Eczema at AAD 2025
Dr. Chovatiya discusses a symposium that he participated in at AAD 2025 focused on chronic hand eczema, reviewing prevalence, subtypes, morphology, and other important considerations for optimizing the treatment of CHE.
Iltefat Hamzavi, MD: Surgical Options for Vitiligo
Dr. Hamzavi reviews the correct patient candidate for surgical therapy for vitiligo and the different options available, including punch grafting, suction blister epidermal grafting, and non-cultured epidermal suspension.
Julien Seneschal, MD, PhD: Immune Pathogenesis of Vitiligo
In an overview from his AAD 2025 presentation, Dr. Seneschal reviews important dimensions of the pathogenesis of vitiligo that necessitate maintenance therapy.